In the current study, AM6545 and AM4113 exhibited vigorous anti-inflammatory activities, as both agents significantly ameliorated the increase in the expression of the proinflammatory mediators TNF-α and IL-6 found in the MetS group. The gene discussed is TNF; the disease is metabolic syndrome.